Cargando…

Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?

BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenect...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlick, Cary Jo R., Khorfan, Rhami, Odell, David D., Merkow, Ryan P., Bentrem, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282211/
https://www.ncbi.nlm.nih.gov/pubmed/32519142
http://dx.doi.org/10.1245/s10434-020-08578-4
_version_ 1783544087731765248
author Schlick, Cary Jo R.
Khorfan, Rhami
Odell, David D.
Merkow, Ryan P.
Bentrem, David J.
author_facet Schlick, Cary Jo R.
Khorfan, Rhami
Odell, David D.
Merkow, Ryan P.
Bentrem, David J.
author_sort Schlick, Cary Jo R.
collection PubMed
description BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenectomy rates over time; (2) evaluate unadjusted lymphadenectomy yield by treatment characteristics; and (3) identify independent factors associated with adequate lymphadenectomy. METHODS: The National Cancer Data Base was used to identify patients who underwent esophagectomy for cancer from 2004 to 2015. Adequate lymphadenectomy trends over time were evaluated using the Cochrane–Armitage test, and lymph node yield by treatment approach was compared using the Mann–Whitney U and Kruskal–Wallis tests. Associations with treatment factors were assessed by multivariable logistic regression. RESULTS: Among 24,413 patients, 9919 (40.6%) had adequate lymphadenectomy. Meeting the nodal threshold increased over time (52.6% in 2015 vs. 26.0% in 2004; p < 0.01). Lymph node yield did not differ based on neoadjuvant therapy (median 12 [interquartile range 7–19] with and without neoadjuvant therapy; p = 0.44). Adequate lymphadenectomy was not associated with neoadjuvant therapy (40.5% vs. 40.8%, odds ratio [OR] 0.94, 95% confidence interval [CI] 0.82–1.07), but was associated with surgical approach (52.7% of laparoscopic cases, OR 1.28, 95% CI 1.06–1.56; 61.2% of robotic cases, OR 1.71, 95% CI 1.34–2.19, vs. 43.5% of open cases), and increasing annual esophagectomy volume (55.6% in the fourth quartile vs. 32.6% in the first quartile; OR 3.57, 95% CI 2.35–5.43). CONCLUSIONS: Despite increases over time, only 50% of patients undergo adequate lymphadenectomy during esophageal cancer resection. Adequate lymphadenectomy was not associated with neoadjuvant therapy. Focusing on surgical approach and esophagectomy volume may further improve adequate lymphadenectomy rates.
format Online
Article
Text
id pubmed-7282211
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72822112020-06-09 Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? Schlick, Cary Jo R. Khorfan, Rhami Odell, David D. Merkow, Ryan P. Bentrem, David J. Ann Surg Oncol Thoracic Oncology BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenectomy rates over time; (2) evaluate unadjusted lymphadenectomy yield by treatment characteristics; and (3) identify independent factors associated with adequate lymphadenectomy. METHODS: The National Cancer Data Base was used to identify patients who underwent esophagectomy for cancer from 2004 to 2015. Adequate lymphadenectomy trends over time were evaluated using the Cochrane–Armitage test, and lymph node yield by treatment approach was compared using the Mann–Whitney U and Kruskal–Wallis tests. Associations with treatment factors were assessed by multivariable logistic regression. RESULTS: Among 24,413 patients, 9919 (40.6%) had adequate lymphadenectomy. Meeting the nodal threshold increased over time (52.6% in 2015 vs. 26.0% in 2004; p < 0.01). Lymph node yield did not differ based on neoadjuvant therapy (median 12 [interquartile range 7–19] with and without neoadjuvant therapy; p = 0.44). Adequate lymphadenectomy was not associated with neoadjuvant therapy (40.5% vs. 40.8%, odds ratio [OR] 0.94, 95% confidence interval [CI] 0.82–1.07), but was associated with surgical approach (52.7% of laparoscopic cases, OR 1.28, 95% CI 1.06–1.56; 61.2% of robotic cases, OR 1.71, 95% CI 1.34–2.19, vs. 43.5% of open cases), and increasing annual esophagectomy volume (55.6% in the fourth quartile vs. 32.6% in the first quartile; OR 3.57, 95% CI 2.35–5.43). CONCLUSIONS: Despite increases over time, only 50% of patients undergo adequate lymphadenectomy during esophageal cancer resection. Adequate lymphadenectomy was not associated with neoadjuvant therapy. Focusing on surgical approach and esophagectomy volume may further improve adequate lymphadenectomy rates. Springer International Publishing 2020-06-09 2020 /pmc/articles/PMC7282211/ /pubmed/32519142 http://dx.doi.org/10.1245/s10434-020-08578-4 Text en © Society of Surgical Oncology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Thoracic Oncology
Schlick, Cary Jo R.
Khorfan, Rhami
Odell, David D.
Merkow, Ryan P.
Bentrem, David J.
Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title_full Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title_fullStr Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title_full_unstemmed Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title_short Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
title_sort adequate lymphadenectomy as a quality measure in esophageal cancer: is there an association with treatment approach?
topic Thoracic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282211/
https://www.ncbi.nlm.nih.gov/pubmed/32519142
http://dx.doi.org/10.1245/s10434-020-08578-4
work_keys_str_mv AT schlickcaryjor adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach
AT khorfanrhami adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach
AT odelldavidd adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach
AT merkowryanp adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach
AT bentremdavidj adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach